In patients with a right ventricle supporting the systemic circulation, the long-term sequelae include heart failure, which is associated with late morbidity and mortality. The present study, a randomized placebo-controlled trial in 88 patients with a systemic right ventricle and a 3.2-year follow-up, investigated whether valsartan had a beneficial effect on the primary end point of right ventricular ejection fraction determined with magnetic resonance imaging. No effect of valsartan on systemic right ventricular function was found, although there was a larger increase in right ventricular volumes and mass in the placebo group than in the valsartan group. Other secondary end points, including exercise capacity and quality of life, showed no differences. In an explanatory analysis, it appeared that there was a favorable effect in symptomatic patients who used valsartan compared with those who used placebo. Because this is also the case in symptomatic patients with acquired left ventricular dysfunction, it is tempting to speculate that inhibition of the renin-angiotensin aldosterone system might benefit symptomatic patients with a systemic right ventricle as well. See p 322.
Cardiovascular Outcomes After the Arterial Switch Operation for D-Transposition of the Great Arteries
As the initial cohort of patients with arterial switch procedures for transposition of the great arteries reach their adult years, it is essential to characterize sequelae and longer-term outcomes to inform and guide screening and surveillance. We, therefore, conducted a retrospective cohort study on 400 patients with arterial switch surgery between 1983 and 1999. Excellent overall (96.7%) and arrhythmia-free (96.6%) survival was observed at 25 years of follow-up. Late fatalities were predominantly attributable to myocardial infarction or sudden death of presumed arrhythmic cause. The few acute coronary events occurred exclusively in infants aged <3.5 months. The most common cardiovascular sequelae were stenoses of the main pulmonary artery or its branches, pulmonary regurgitation, neoaortic stenosis and regurgitation, and coronary artery disease. Nearly one quarter of the patients required reintervention by 25 years of follow-up, whether surgical or percutaneous. Adverse cardiovascular events were predicted by a single right coronary artery and acute postoperative low cardiac output syndrome. Despite the prevalent postoperative sequelae and occasional adverse events, the mean left ventricular ejection fraction was 60.3% at the last follow-up, with 97.3% of patients having New York Heart Association class I symptoms. The peak oxygen uptake was 86.1% of predicted values. Chronotropic incompetence was nevertheless identified in more than one third of patients, perhaps reflecting sympathetic denervation. These results compare favorably with the much higher arrhythmia burden, incidence of sudden death, and prevalence of systemic (right) ventricular dysfunction previously reported in patients with atrial switch (ie, Mustard or Senning) procedures. See p 331.
Long-term Leisure-time Physical Activity and Serum Metabolome
The modern environment is conducive to a sedentary lifestyle with an increased propensity for adverse metabolic profiles, obesity, and cardiometabolic diseases. Long-term physical activity is known to reduce metabolic risks, although specific molecular information on its effects on systemic metabolism is sparse. We studied twin pairs who were discordant for physical activity for >30 years and individuals from 3 population-based cohorts who were persistently (≥5 years) active or inactive. Because physical activity is likely to affect health via multiple mechanisms, we applied serum nuclear magnetic resonance metabolomics for the comprehensive coverage of systemic metabolism. Our results illustrate that persistent physical activity was associated with a characteristic multivariate metabolic profile both in the twins and in the pairs identified from the population cohorts. To summarize, isoleucine, α1-acid glycoprotein, and glucose were lower in the physically active than in the inactive individuals. In the physically active individuals, the serum fatty acid composition was toward less saturation and the lipoprotein subclasses profile toward lower very-low-density lipoprotein and higher large and very large high-density lipoprotein particle concentrations. The findings persisted after adjustment for body mass index. Polyunsaturated fatty acids and very-low-density lipoprotein metabolism were further linked to specific adipose tissue gene set expressions. The differences found between persistently physically active and inactive individuals in the circulating metabolome coherently indicate better overall metabolic health in the physically active than in the inactive individuals. These findings support the efforts for increased physical activity to reduce the public health burden of metabolic disorders and cardiometabolic diseases. See p 340.
An Early Appointment to Outpatient Cardiac Rehabilitation at Hospital Discharge Improves Attendance at Orientation: A Randomized, Single-Blind, Controlled Trial
Outpatient cardiac rehabilitation (CR) is a highly effective but significantly underutilized intervention for patients after an acute myocardial infarction, percutaneous coronary intervention, or cardiac surgery. The mortality reduction from CR is similar to that seen with statin medications (range 20%-35%), yet only ≈30% of eligible patients participate in CR. National organizations, including the American Heart Association, have called for improvement of this important quality gap. One contributing modifiable factor may be the timing of the first appointment for CR. Recent retrospective studies Volume 127 ◼ Number 3 ◼ January 22, 2013 have suggested that for each day of delay between hospital discharge and CR orientation, there is a 1% loss in CR participation. We prospectively randomized 148 patients to receive either an early or standard appointment to CR. Attendance occurred at a median of 8 versus 42 days per group, respectively. We found a significant 18% absolute and 56% relative improvement in attendance at orientation in the early group. Although the effects of an early appointment were limited to attendance at orientation, this technique was simple, safe, and was easily incorporated into the referral routine. Consequently, when coupled with other known effective techniques (automatic-referral and liaison-facilitated referral), an early appointment could potentially increase patient participation in CR and reduce the size of this important quality gap in the secondary prevention of heart disease. See p 349.
Incremental Value of the Preoperative Echocardiogram to Predict Mortality and Major Morbidity in Coronary Artery Bypass Surgery
Echocardiography is commonly performed before coronary artery bypass surgery to assess left ventricular systolic function and concomitant valvular lesions. Beyond these basic parameters, this study of 854 patients has shown that left ventricular diastolic function and right ventricular function merit careful consideration because they carry meaningful information about the patient's risk for postoperative mortality and major morbidity. A derivation cohort at the Massachusetts General Hospital was used to identify optimal echocardiographic predictors, which were subsequently confirmed in a validation cohort at the Jewish General Hospital. Specifically, the presence of restrictive diastolic filling and abnormal right ventricular function (as measured by fractional area change or myocardial performance index) were each associated with a 2-to 3-fold increase in in-hospital mortality or major morbidity. These echocardiographic parameters demonstrated an incremental value above clinical covariables and the Society of Thoracic Surgeons Risk Score, resulting in improved discrimination and reclassification of risk. The prognostic value of the preoperative echocardiogram extended past the in-hospital timeframe, with right ventricular function and pulmonary arterial systolic pressure emerging as independent predictors of all-cause mortality after a median of 3.2 years of follow-up. Although previous studies had evaluated selected echocardiographic parameters, the independent value of each parameter within the context of a comprehensive echocardiogram remained unclear. With the help of this study, clinicians will be in a better position to integrate echocardiographic findings in their evaluation of operative risk and ultimately make more informed treatment decisions for their patients. See p 356.
Uremic Serum and Solutes Increase Post-Vascular Interventional Thrombotic Risk Through Altered Stability of Smooth Muscle Cell Tissue Factor
Advances in cardiovascular therapeutics and techniques have expanded the pool of patients amenable for percutaneous intervention, and, increasingly, higher-risk patients with comorbidities such as concomitant chronic renal failure undergo complex interventions. However, these subsets are often at higher risk for treatment failures, and chronic renal failure and end-stage renal disease have been implicated as leading risk factors in endovascular stent thrombosis, a condition associated with a nearly 50% mortality rate. Although uremia has long been recognized as thrombogenic, the mechanisms and markers of postinterventional thrombosis remain poorly elucidated, thus limiting our ability to risk stratify and treat these patients effectively. In this study, we show that uremia, independent of diabetes mellitus (the leading cause of chronic renal failure), mediates postinterventional thrombosis by upregulating local tissue factor levels in vascular smooth muscle cells, which are the principal cells exposed to blood after endovascular manipulation. We identify specific and novel role of uremic solutes in regulating tissue factor through ubiquitination and subsequent degradation. Our data indicate that vascular smooth muscle cell tissue factor is the critical mediator of enhanced thrombogenicity in the postinterventional environment when exposed to uremia, offering a potential therapeutic target in these patients. We further identify specific uremic solutes in the postinterventional milieu that can be explored as biomarkers to stratify thrombotic risk in patients with chronic renal failure before intervention. See p 365.
Drug Resistance and Pseudoresistance: An Unintended Consequence of Enteric Coating Aspirin
Low-dose aspirin reduces the secondary incidence of and mortality from stroke and myocardial infarction by the irreversible inhibition of the platelet cyclooxygenase/ thromboxane A 2 pathway. The term aspirin resistance is often used to imply treatment failure, although clinical outcomes have rarely been assessed. More commonly, a patient is classified as resistant to aspirin if platelet aggregation, measured on a single occasion, is not depressed to an arbitrary degree. Estimates of the frequency of aspirin resistance have varied widely. This study determined the incidence of true pharmacological resistance to aspirin-internally consistent functional and biochemical estimates of the inhibition of the cyclooxygenase/thromboxane A 2 pathway, stability over time, and drug specificity-in the general population. Not a single case of true drug resistance such as might result from gene variants in the aspirin metabolizing or target pathway was found in 400 volunteers. However, test doses of enteric coated aspirin, but not regular immediate release aspirin, were associated with variable absorption, which would have been inaccurately interpreted as resistance by a single pointof-care test. Measurement of a urinary thromboxane metabolite, an U.S. Food and Drug Administration-approved approach to determining aspirin response status, was found unsuitable for diagnosing aspirin resistance in an individual, although it reflects inhibition of the aspirin target pathway in a population. See p 377.
Vascular Smooth Muscle Cell Sirtuin 1 Protects Against DNA Damage and Inhibits Atherosclerosis
Human atherosclerotic plaques show extensive DNA damage, cell death (through apoptosis), and cell senescence. Although these processes are thought to promote an unstable plaque phenotype predisposing to acute coronary syndromes, the mechanisms underlying their regulation in vivo is not known. The sirtuin 1 (SIRT1) deacetylase enzyme has been implicated in regulating multiple degenerative diseases, through effects on energy metabolism, longevity, cell proliferation, and cell death (among others). We show that SIRT1 is reduced in human atherosclerosis, in particular, in vascular smooth muscle cells in both the plaque and underlying vessel wall. SIRT1 controls DNA repair, apoptosis, and cell senescence in the vessel. SIRT1 is reduced by a high-fat diet, and both fat feeding in vivo and oxidized low-density lipoprotein in vitro increase DNA damage. Smooth muscle cell-specific loss of SIRT1 in mice increases DNA damage and apoptosis, accelerates atherosclerosis, and causes extensive medial degeneration. Our data show that SIRT1 is a powerful protective protein in the vessel wall, regulating oxidative DNA damage and keeping cells alive. Loss of SIRT1 promotes atherosclerosis and other vascular pathologies, indicating that elective augmentation of SIRT1 becomes an attractive therapeutic target. The results of clinical studies with agents that increase SIRT1 activity in atherosclerosis are awaited. See p 386.
